Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma Clinical Trials in Boston, Massachusetts

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy